Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Kenneth Solomon, Marc Olesen

Premium

Rubicon Genomics has hired Kenneth Solomon as director of sales and marketing. He has previously held positions at Centocor Ortho Biotech, Pharmacia/Searle, Biomet, and Boehringer Manheim. He holds an MBA from Michigan State University and a BA from Calvin College.


DNAnexus has appointed Marc Olesen as president and chief operating officer to help the company as it readies the commercial launch of its new genomic data management and analysis platform.

Olesen was most recently senior vice president and general manager of network and cloud security for McAfee. He was also vice president of software-as-a-service for Mercury Interactive, which was acquired by Hewlett-Packard. He holds a BA in economics and an MS in industrial engineering from Stanford University.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.